The Research Institute is governed by the Board of Trustees (BOT). The BOT shall consist of 6 elected trustees from the ACCP membership and between 3 and 6 appointed trustees and four Ex-Officio Members. The BOT is responsible for, but not limited to, accomplishing the following:
- Develop strategic plans and policies to conduct business and for future growth;
- Identify, prioritize, and implement research and education agendas and programs for the corporation; and
- Guide and actively participate in the fund raising efforts of the Corporation.
For a list of Chairs and Board Members on the Board of Trustees since 1985, click here.
|
Chair
Susan C. Fagan, Pharm.D., FCCP, BCPS
|
|
Vice-Chair
Stuart T. Haines, Pharm.D., FCCP, BCPS
|
|
Secretary, Ex-Officio ACCP Research Institute, Director, Research
Jacqueline S. Marinac, PharmD, BCPS
|
|
Treasurer
Mark A. Munger, Pharm.D., FCCP
|
|
Ex-Officio Trustee ACCP Executive Director
Michael S. Maddux, Pharm.D., FCCP
|
|
Elected Trustee
John D. Cleary, Pharm.D., FCCP, BCPS
|
|
Elected Trustee
Thomas C. Dowling, Pharm.D., Ph.D.
|
|
Elected Trustee
Howard McLeod, Pharm.D., FCCP
|
|
Elected Trustee
Gary C. Yee, Pharm.D., FCCP, BCOP
|
|
Appointed Trustee
James Caro, R.Ph., MBA
|
|
|
Appointed Trustee
Richard F. de Leon, Pharm.D.
|
|
Appointed Trustee
Mary Anne Koda-Kimble, Pharm.D.
|